July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Morphological Changes of the Retinal Choroid in Severe Alzheimer’s Disease: A Histopathological Study
Author Affiliations & Notes
  • Fred N. Ross-Cisneros
    Neuro-Ophthalmology, Doheny Eye Institute, Los Angeles, California, United States
  • Samuel Asanad
    Neuro-Ophthalmology, Doheny Eye Institute, Los Angeles, California, United States
    Ophthalmology, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States
  • Ernesto Barron
    Imaging Core Facility, Doheny Eye Institute, Los Angeles, California, United States
  • Alec Chan Golston
    Biostatistics, School of Public Health, University of California Los Angeles, Los Angeles, California, United States
  • Eric A Barron
    Imaging Core Facility, Doheny Eye Institute, Los Angeles, California, United States
  • Alfredo A Sadun
    Neuro-Ophthalmology, Doheny Eye Institute, Los Angeles, California, United States
    Ophthalmology, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States
  • Footnotes
    Commercial Relationships   Fred Ross-Cisneros, None; Samuel Asanad, None; Ernesto Barron, None; Alec Chan Golston, None; Eric Barron, None; Alfredo Sadun, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 306. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Fred N. Ross-Cisneros, Samuel Asanad, Ernesto Barron, Alec Chan Golston, Eric A Barron, Alfredo A Sadun; Morphological Changes of the Retinal Choroid in Severe Alzheimer’s Disease: A Histopathological Study. Invest. Ophthalmol. Vis. Sci. 2018;59(9):306.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The choroid exhibits significant thinning in Alzheimer's Disease (AD) as measured in vivo using optical coherence tomography (OCT). This study aims to histopathologically confirm these findings by performing a morphological analysis of the choroidal area in severe AD using postmortem tissue. We hypothesize that the degenerative effects of AD will produce a significant reduction in choroidal thickness.

Methods : 5 AD postmortem eyes (mean age: 86.2±15.10 years) were compared to 5 age-matched controls (mean age: 84.8±14.75 years). Tissues were fixed in phosphate-buffered formalin, dissected horizontally through the middle of the optic nerve, embedded into paraffin, sectioned and stained with hematoxylin and eosin. Choroidal thickness was measured from the posterior border of the retinal pigment epithelium (RPE) to the anterior sclera. Measurements were performed at 18 different points along the horizontal meridian beginning from the edge of the optic disc at 100 and 500 μm intervals spanning a total distance of 4.5 mm in both nasal and temporal directions. Welch’s t-test was used for statistical analysis.

Results : Mean total choroidal thickness in the nasal region was significantly thinner in AD (1187.60 ± 9.34μm) compared to controls (1545.77 ± 14.82μm; p< 0.0001). Nasal thinning in AD was found to be most severe between 2.5 to 3.5mm from the optic disc edge. On the contrary, in the temporal region, mean choroidal thickness was significantly larger in AD relative to controls, specifically in the perimacular region (829.77 ± 18.85μm in AD and 678.08 ± 11.24μm in controls; p=0.01). Qualitatively, the large vessel layer of the choroid in the temporal region was observed to be larger in AD relative to controls, especially in the perimacular region.

Conclusions : Choroidal thinning was topographically confirmed in the nasal region and is consistent with clinical OCT studies in mild to moderate AD patients. Importantly, the choroid in severe AD was significantly thicker in the perimacular region, where the retina is reportedly most atrophic. These findings support the role of vascular factors in AD pathogenesis and correlate vessel layer changes in severe disease stages.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×